32 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
.
Apexigen’s business activities may be subject to the FCPA and similar anti-bribery and anti-corruption laws.
Apexigen’s business activities may … be subject to the Foreign Corrupt Practices Act (“FCPA”) and similar anti-bribery or anti-corruption laws, regulations, or rules of other countries
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
, as amended; or (c) made any other payment in violation of applicable anti-bribery/anti-corruption Laws. The Company has adopted and maintains adequate … compliance with all applicable anti-bribery/anti-corruption Laws.
Section 3.21. Interested Party Transactions. Except for employment relationships
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
, as amended; or (c) made any other payment in violation of applicable anti-bribery/anti-corruption Laws. The Company has adopted and maintains adequate … with all applicable anti-bribery/anti-corruption Laws.
Section 3.21. Interested Party Transactions. Except for employment relationships and the payment
424B3
pdjlhkc
10 Apr 23
Prospectus supplement
4:03pm
424B3
1x49m 46cwbg
10 Apr 23
Prospectus supplement
4:02pm
POS AM
rjoaiddq052oy b8j
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
sugr 0ic3pr50
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
vq3niz
9 Sep 22
Prospectus supplement
4:40pm
424B3
dhzx g331mcqz
9 Sep 22
Prospectus supplement
4:38pm
424B3
n15l3g
6 Jul 22
Prospectus supplement
4:18pm